quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:57:17·63d
INSIDERFiling
Evolus Inc. logo

Officer Avelar Rui was granted 94,913 shares, increasing direct ownership by 27% to 451,734 units (SEC Form 4)

EOLS· Evolus Inc.
Health Care
Original source

Companies

  • EOLS
    Evolus Inc.
    Health Care

Recent analyst ratings

  • Aug 6UpdateNeedham-
  • Apr 17UpdateBTIG Research$21.00
  • Jan 29UpdateBarclays$16.00
  • Jun 23UpdateNeedham$18.00
  • May 12UpdateBarclays$10.00
  • Jan 20UpdateTruist$11.00

Related

  • PR10d
    Evolus to Report First Quarter Financial Results on May 4, 2026
  • PR22d
    Telix Appoints David Gill as Non-Executive Director
  • PR24d
    Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Evolus Inc.
  • INSIDER34d
    SEC Form 4 filed by Moatazedi David
  • INSIDER34d
    SEC Form 4 filed by Avelar Rui
  • PR34d
    Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • INSIDER36d
    SEC Form 4 filed by Avelar Rui
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022